5414x Link

: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas.

"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc .

: £12.9 million (+27.4%), supported by synthetic biology. : Completed a programme resulting in an approximately

The full regulatory document can be accessed through the London Stock Exchange or financial news platforms like ADVFN . Interim results for the 6 months ended 30 June 25

: A refined commercial strategy identified high-priority opportunities in applied and research markets worth an estimated $13 to $14 billion . The full regulatory document can be accessed through

Co-founder and CEO announced he will step down from his role and the board by the end of 2026.

: Introduced next-generation automated flow cell lines and strengthened quality assurance to ISO 13485 standards. : Introduced next-generation automated flow cell lines and

: £13.0 million (+52.9%), driven by AMR and EMEAI growth.